Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors — Stella

Recruiting

Back to Neuroblastoma trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

University of Florida, Gainesville, Florida

Key details

Phase

Early testing / Safety & dosing

Sponsor

University of Florida

Enrollment target

~27 participants

Started

February 2026

Primary completion

February 2030

Age range

6 Months – 25 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov